Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction.i "Penumbra is a ...
Venous Therapies
This channel includes news and new technology innovations of Venous Therapies including deep vein thrombosis (DVT) and vena cava filters.
-
-
Jan. 8, 2026 — Compremium AG recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel solution designed to directly measure central ...
-
April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin alongside the P2Y12 inhibitor ticagrelor one month after undergoing percutaneous ...
-
Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of April. The picks are based on Google Analytics of the DAIC website's video ...
Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...
January 19, 2026
Jan. 8, 2026 — Compremium AG recently announced that the U.S. Food and Drug Administration (FDA) has granted ...
January 13, 2026
Sept. 9, 2025 — The American Venous Forum (AVF), International Society on Thrombosis and Haemostasis (ISTH), National ...
September 10, 2025
April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...
April 16, 2024
April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin ...
April 08, 2024
March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...
March 21, 2024
January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia ...
January 11, 2024
October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking ...
October 31, 2023
January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...
January 11, 2023
November 21, 2022 — New research published in the Journal of the American College of Cardiology shows the use of drug ...
November 21, 2022
November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...
November 02, 2022
November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...
November 02, 2022
October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...
October 31, 2022
October 14, 2022
Feature | Thrombectomy Devices | By Global Market Insights
The global thrombectomy devices market is poised to experience substantial expansion, owing to the emergence of ...
June 27, 2022